CCR5 expression correlated with tumor stage/metastasis, while CCL5 linked to survival. Exogenous CCL5 boosted proliferation, whereas shRNA and Maraviroc suppressed it dose-dependently. Maraviroc also enhanced apoptosis, altered cytoskeleton, and reduced neck Metastasis in vivo. The gene discussed is CCL5; the disease is neoplasm.